These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24709419)

  • 1. KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation.
    Shukla S; Allam US; Ahsan A; Chen G; Krishnamurthy PM; Marsh K; Rumschlag M; Shankar S; Whitehead C; Schipper M; Basrur V; Southworth DR; Chinnaiyan AM; Rehemtulla A; Beer DG; Lawrence TS; Nyati MK; Ray D
    Neoplasia; 2014 Feb; 16(2):115-28. PubMed ID: 24709419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
    Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
    J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted degradation of KRAS by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivo.
    Ma Y; Gu Y; Zhang Q; Han Y; Yu S; Lu Z; Chen J
    Mol Cancer Ther; 2013 Mar; 12(3):286-94. PubMed ID: 23288781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smurf2 regulates the degradation of YY1.
    Jeong HM; Lee SH; Yum J; Yeo CY; Lee KY
    Biochim Biophys Acta; 2014 Sep; 1843(9):2005-11. PubMed ID: 24803334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.
    Ray D; Ahsan A; Helman A; Chen G; Hegde A; Gurjar SR; Zhao L; Kiyokawa H; Beer DG; Lawrence TS; Nyati MK
    Neoplasia; 2011 Jul; 13(7):570-8. PubMed ID: 21750651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
    Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
    Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
    Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
    Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett's Progression to Esophageal Adenocarcinoma.
    Ray P; Nancarrow DJ; Ferrer-Torres D; Wang Z; San Martinho M; Hinton T; Wu JH; Wu A; Turgeon DK; Hammer MA; Dame MK; Lawrence TS; O'Brien PJ; Spence JR; Beer DG; Ray D
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):129-149. PubMed ID: 34416429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
    Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas.
    McCleland ML; Adler AS; Deming L; Cosino E; Lee L; Blackwood EM; Solon M; Tao J; Li L; Shames D; Jackson E; Forrest WF; Firestein R
    Clin Cancer Res; 2013 Feb; 19(4):773-84. PubMed ID: 23224736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
    Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
    Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2).
    Kim S; Jho EH
    J Biol Chem; 2010 Nov; 285(47):36420-6. PubMed ID: 20858899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS.
    Bansod S; Dodhiawala PB; Geng Y; Bulle A; Liu P; Li L; Townsend R; Grierson PM; Held JM; Adhikari H; Lim KH
    Cell Rep; 2024 Sep; 43(9):114667. PubMed ID: 39178114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
    Li Y; Sun XX; Elferich J; Shinde U; David LL; Dai MS
    J Biol Chem; 2014 Feb; 289(8):5097-108. PubMed ID: 24403071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt enhances Runx2 protein stability by regulating Smurf2 function during osteoblast differentiation.
    Choi YH; Kim YJ; Jeong HM; Jin YH; Yeo CY; Lee KY
    FEBS J; 2014 Aug; 281(16):3656-66. PubMed ID: 24961731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication.
    Tan R; He W; Lin X; Kiss LP; Liu Y
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1076-83. PubMed ID: 18353873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expression.
    Hsu KS; Kao HY
    J Biol Chem; 2013 Aug; 288(35):25375-25386. PubMed ID: 23861398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
    Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
    J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation.
    Pan Y; Li R; Meng JL; Mao HT; Zhang Y; Zhang J
    J Immunol; 2014 May; 192(10):4758-64. PubMed ID: 24729608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.